VKH
ESPR

Virtu KCG Holdings’s Esperion Therapeutics ESPR Stock Holding History

Virtu KCG Holdings’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$419K Sell
9,047
-30,149
-77% -$1.11M 0.01% 1313
2017
Q1 		$1.38M Buy
+39,196
New +$898K 0.04% 480
2016
Q3 		– Sell
-41,780
Closed -$413K – 3167
2016
Q2 		$413K Buy
+41,780
New +$692K 0.01% 1558
2016
Q1 		– Sell
-10,296
Closed -$229K – 3040
2015
Q4 		$229K Sell
10,296
-14,904
-59% -$376K ﹤0.01% 2523
2015
Q3 		$594K Buy
+25,200
New +$1.58M 0.01% 1361

Other funds holding ESPR

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return